Antisuicidal Effects in Mood Disorders: Are They Unique to Lithium?

Pharmacopsychiatry

Volumn 51, Issue 5, 2018, Pages 177-188

  Tondo, Leonardo ^a,b,c   Baldessarini, Ross J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c Lucio Bini Mood Disorders Center   (Italy)

Author keywords

anticonvulsants; antidepressants; antipsychotics; bipolar I and II disorders; lithium; major depressive disorder; suicide

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; DRINKING WATER; GROUND WATER; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; VALPROIC ACID; LITHIUM DERIVATIVE; TRANQUILIZER;

BIPOLAR DISORDER; DRUG BLOOD LEVEL; HOMICIDE; HUMAN; MAJOR AFFECTIVE DISORDER; MAJOR DEPRESSION; META ANALYSIS; MOOD DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; PSYCHOLOGY;

ANTIMANIC AGENTS; HUMANS; LITHIUM COMPOUNDS; MOOD DISORDERS; SUICIDE;

EID: 85046007953     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/a-0596-7853     Document Type: Review

References (136)

1. Ahrens B. Müller-Oerlinghausen B. Schou M. et al. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord: 1995; 33 67 75
2. Müller-Oerlinghausen B. Müser-Causemann B. Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord: 1992; 25 261 269
3. Tondo L. Jamison K. R. Baldessarini R. J. Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci: 1997; 836 339 351
4. Hennen J. Baldessarini R. J. Suicidal risk during treatment with clozapine: A meta-analysis. Schizophr Res: 2005; 73 139 145
5. Meltzer H. Y. Alphs L. Green A. I. et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry: 2003; 60 82 91
6. World Health Organization (WHO). Suicide Rates Age-Standardized by Country. 2015; Accessed at: http://apps.who.int/gho/data/view.main.MHSUICIDEREGv?lang = en Accessed on: December 13, 2017
7. Harris E. C. Barraclough B. Excess mortality of mental disorder. Brit J Psychiatry: 1998; 173 11 53
8. Schaffer A. Isometsä E. T. Tondo L. et al. Epidemiology neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disord Task Force on Suicide in Bipolar Disorder. ANZJP: 2015; 49 785 802
9. Tondo L. Pompili M. Forte A. et al. Suicide attempts in bipolar disorders: Comprehensive review of 101 reports. Acta Psychiatr Scand: 2016; 133 174 186
10. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-5. 5th ed. Washington, DC APA: 2013
11. Swann A. C. Lafer B. Perugi G. et al. Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure course of illness and diagnosis. Am J Psychiatry: 2013; 170 31 42
12. Novick D. M. Swartz H. A. Frank E. Suicide attempts in bipolar I and bipolar II disorder: A review and meta-analysis of the evidence. Bipolar Disord: 2010; 12 1 9
13. Baldessarini R. J. ed. Chemotherapy in Psychiatry. New York Springer: 2013
14. Baldessarini R. J. Vieta E. Calabrese JR, et al. Bipolar depression: Overview and commentary. Harv Rev Psychiatry: 2010; 18 143 157
15. Baldessarini R. J. Faedda G. L. Offidani E. et al. Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: A review. J Affect Disord: 2013; 148 129 135
16. Faedda G. L. Marangoni C. Serra G. et al. Precursors of bipolar disorders: A systematic literature review of prospective studies. J Clin Psychiatry: 2015; 76 614 624
17. Koukopoulos A. Sani G. Koukopoulos A. E. et al. Melancholia agitata and mixed depression. Acta Psychiatr Scand: 2007; 115 50 57
18. Koukopoulos A. Reginaldi D. Tondo L. et al. Course sequences in bipolar disorder: Depressions preceding or following manias or hypomanias. J Affect Disord: 2013; 151 105 110
19. Pacchiarotti I. Bond D. J. Baldessarini R. J. et al. The International Society for Bipolar Disorder (ISBD) task force report on antidepressant use in bipolar disorder. Am J Psychiatry: 2013; 170 1249 1262
20. Vázquez G. H. Tondo L. Undurraga J. et al. Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol: 2013; 16 1673 1685
21. Vázquez G. H. Tondo L. Undurraga J. et al. Pharmacological treatment of bipolar depression. Advan Psychiatr Treat: 2014; 20 193 201
22. De Dios C. Ezquiaga E. Garcia A. et al. Time spent with symptoms in a cohort of bipolar disorder outpatients in Spain: A prospective 18-month follow-up study. J Affect Disord: 2010; 125 74 81
23. Forte A. Baldessarini R. J. Tondo L. et al. Long-term morbidity in bipolar-I bipolar-II and unipolar major depressive disorders. J Affect Disord: 2015; 178 71 78
24. Vázquez G. H. Lolich M. Cabrera C. et al. Mixed symptoms in major depressive and bipolar disorders: A systematic review. J Affect Disord: 2018; 225 756 760
25. Goldsmith S. Pellmar T. Kleinman A. Bunney W. E. eds. Reducing Suicide: A National Imperative. Washington, DC National Academies Press: 2002
26. Jacobs D. Brewer M. APA practice guideline provides recommendations for assessing and treating patients with suicidal behaviors. Psychiatr Ann: 2004; 34 373 380
27. Tondo L. Baldessarini R. J. Reduction of suicidal behavior in bipolar disorder patients during long-term treatment with lithium. In: Koslow S. Ruiz P. Nemeroff C. eds. A Concise Guide to Understanding Suicide. Cambridge, UK Cambridge University Press: 2014; 217 218
28. Tondo L. Baldessarini R. J. Suicide in bipolar disorder. In: Yildiz A. Nemeroff C. Ruiz P. eds. The Bipolar Book: History, Neurobiology and Treatment. New York Oxford University Press: 2015; 509 528
29. Weinger R. ed. Practice of Electroconvulsive Therapy: Recommendations for Treatment Training and Privileging. Task Force Report of the American Psychiatric Association. 2nd ed. Washington, DC American Psychiatric Press: 2002
30. Sareen J. Isaak C. Katz L. Y. et al. Promising strategies for advancement in knowledge of suicide risk factors and prevention. Am J Prev Med: 2014; 47 S257 S263
31. Sheehan D. Giddens J. eds. Suicidality: A Roadmap for Assessment Treatment. Tampa, FL Harm Research Press: 2015
32. Brenner L. A. Breshears R. E. Betthauser L. M. et al. Implementation of a suicide nomenclature within two VA healthcare settings. J Clin Psychol Med Settings: 2011; 18 116 128
33. Crosby A, Ortega L, Melanson C. Self-Directed Violence Surveillance: Uniform Definitions and Recommended Data Elements Version 10 Atlanta: Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Violence Prevention; 2011. Accessed at: https://www.cdc.gov/violenceprevention/pdf/self-directed-violence-a.pdf Accessed on: December 13, 2017
34. U.S. Food and Drug Administration. Guidance for Industry Suicidal Ideation and Behavior: Prospective Assessment of Occurrence in Clinical Trials US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER); 2012. Accessed at: https://www.fda.gov/downloads/drugs/guidances/ucm225130.pdf
35. Cipriani A. Hawton K. Stockton S. Lithium in the prevention of suicide in mood disorders: Updated systematic review and meta-analysis. BMJ: 2013; 346 f3646
36. Smith K. A. Cipriani A. Lithium and suicide in mood disorders: Updated meta-review of the scientific literature. Bipolar Disord: 2017; 19 575 586
37. Baldessarini R. J. Tondo L. Davis P. et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord: 2006; 8 625 639
38. Tondo L. Hennen J. Baldessarini R. J. Lower suicide risk with long-term lithium treatment in major affective illness: A meta-analysis. Acta Psychiatr Scand: 2001; 104 163 172
39. Bauer M. Bschor T. Kunz D. et al. Double-blind placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am J Psychiatry: 2000; 157 1429 1435
40. Calabrese J. R. Bowden C. L. Sachs G. et al Placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry: 2003; 64 1013 1024
41. Glen A. I. Johnson A. L. Shepherd M. Continuation therapy with lithium and amitriptyline in unipolar depressive illness: A randomized double-blind controlled trial. Psychol Med: 1984; 14 37 50
42. Greil W. Ludwig-Mayerhofer W. Erazo N. et al. Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: A randomised study. J Affect Disord: 1996; 40 179 190
43. Greil W. Ludwig-Mayerhofer W. Erazo N. et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders-a randomised study. J Affect Disord: 1997; 43 151 161
44. Lauterbach E. Felber W. Müller-Oerlinghausen B. et al. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: A randomised placebo-controlled 1-year trial. Acta Psychiatr Scand: 2008; 118 469 479
45. Licht R. W. Nielsen J. N. Gram L. F. et al. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: An open randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord: 2010; 12 483 493
46. Prien R. F. Klett C. J. Caffey E. M. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry: 1973; 29 420 425
47. Thies-Flechtner K. Müller-Oerlinghausen B. Seibert W. et al. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Pharmacopsychiatry: 1996; 29 103 107
48. Tohen M. Greil W. Calabrese J. R. et al Olanzapine versus lithium in the maintenance treatment of bipolar disorder: A 12-month randomized double-blind controlled clinical trial. Am J Psychiatry: 2005; 162 1281 1290
49. Vita A. De Peri L. Sacchetti E. Lithium in drinking water and suicide prevention. Int Clin Psychopharmacol: 2015; 30 1 5
50. Baldessarini R. J. Tondo L. Lithium and suicidal risk. Bipolar Disord: 2008; 10 114 115
51. Guzzetta F. Tondo L. Centorrino F. et al. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry: 2007; 68 380 383
52. Tondo L. Baldessarini R. J. Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol Psichiatr Soc: 2009; 18 179 183
53. Blüml V. Regier M. D. Hlavin G. et al. Lithium in the public water supply and suicide mortality in Texas. J Psychiatr Res: 2013; 47 407 411
54. Dawson E. B. Moore T. D. McGanity W. J. Relationship of lithium metabolism to mental hospital admission and homicide. Dis Nerv Sys: 1972; 33 546 556
55. Giotakos O. Tsouvelas G. Nisianakis P. et al. Negative association between lithium in drinking water and the Incidences of homicides in Greece. Biol Trace Elem Res: 2015; 164 165 168
56. Giotakos O. Nisianakis P. Tsouvelas G. Lithium in the public water supply and suicide mortality in Greece. Biol Trace Elem Res: 2013; 156 376 379
57. Helbich M. Leitner M. Kapusta N. D. Lithium in drinking water and suicide mortality: interplay with lithium prescriptions. Brit J Psychiatry: 2015; 207 64 71
58. Helbich M. Blüml V. Leitner M. et al. Does altitude moderate the impact of lithium on suicide? A spatial analysis of Austria. Geospat Health: 2013; 7 209 218
59. Helbich M. Leitner M. Kapusta N. D. Geospatial examination of lithium in drinking water and suicide mortality. Int J Health Geograph: 2012; 11 19
60. Ishii N. Terao T. Araki Y. et al. Low risk of male suicide and lithium in drinking water. J Clin Psychiatry: 2015; 76 319 326
61. Kabacs N. Memon A. Obinwa T. et al. Lithium in drinking water and suicide rates across the East of England. Brit J Psychiatry: 2011; 198 406 407
62. Kapusta N. D. Mossaheb N. Etzersdorfer E. et al. Lithium in drinking water and suicide mortality. Brit J Psychiatry: 2011; 198 346 350
63. Knudsen N. N. Schullehner J. Hansen B. et al. Lithium in drinking water and incidence of suicide: a nationwide individual-level cohort study with 22 years of follow-up. Int J Environ Res Pub Health: 2017; 14 627 640
64. König D. Baumgartner J. Blüml V. et al. [Impact of natural lithium resources on suicide mortality in Chile 2000-2009: A geographical analysis]. Neuropsychiatrie: 2017; 31 70 76
65. Liaugaudaite V. Mickuviene N. Raskauskiene N. et al. Lithium levels in the public drinking water supply and risk of suicide: a pilot study. J Trace Elem Med Biol: 2017; 43 197 201
66. Ohgami H. Terao T. Shiotsuki I. et al. Lithium levels in drinking water and risk of suicide. Brit J Psychiatry: 2009; 194 464 465
67. Pompili M. Vichi M. Dinelli E. et al. Relationships of local lithium concentrations in drinking water to regional suicide rates in Italy. World J Biol Psychiatry: 2015; 16 567 574
68. Schrauzer G. N. Shrestha K. P. Lithium in drinking water and the incidences of crimes suicides and arrests related to drug addictions. Biol Trace Elem Res: 1990; 25 105 113
69. Shiotsuki I. Terao T. Ishii N. et al. Trace lithium is inversely associated with male suicide after adjustment of climatic factors. J Affect Disord: 2016; 189 282 286
70. Sugawara N. Yasui-Furukori N. Ishii N. et al. Lithium in tap water and suicide mortality in Japan. Int J Environ Res Pub Health: 2013; 10 6044 6048
71. Hayes J. F. Marston L. Walters K. et al. Lithium vs valproate vs olanzapine vs quetiapine as maintenance monotherapy for bipolar disorder: A population-based UK cohort study using electronic health records. World Psychiatry: 2016; 15 53 85
72. Hayes J. F. Pitman A. Marston L. et al. Self-harm, unintentional injury, and suicide in bipolar disorder during maintenance mood stabilizer treatment a UK population-based electronic health records study. JAMA Psychiatry: 2016; 73 630 637
73. Oquendo M. Hanga M. Galfalvy C. et al. Treatment of suicide attempters with bipolar disorder: Randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. Am J Psychiatry: 2011; 168 1050 1056
74. Sondergård L. Lopez A. G. Andersen P. K. et al. Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disord: 2008; 10 87 94
75. Baldessarini R. Tondo L. Suicidal risks during treatment of bipolar disorder patients with lithium vs anticonvulsants. Pharmacopsychiatry: 2009; 42 72 75
76. U.S. Food and Drug Administration. Statistical Review and Evaluation: Antiepileptic Drugs and suicidality; 2008. Accessed at: https://www.fda.gov/downloads/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm192556.pdf Accessed on: December 15, 2017
77. Goodwin F. K. Fireman B. Simon G. E. et al. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA: 2003; 290 1467 1473
78. Posner K. Oquendo M. A. Gould M. et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry: 2007; 164 1035 1043
79. Yerevanian B. I. Koek R. J. Mintz J. Bipolar pharmacotherapy and suicidal behavior: Lithium, divalproex and carbamazepine. J Affect Disord: 2007; 103 5 11
80. Smith E. G. Sondergård L. Lopez A. G. et al. Association between consistent purchase of anticonvulsants or lithium and suicide risk: A longitudinal cohort study from Denmark 1995-2001. J Affect Disord: 2009; 117 162 167
81. Fountoulakis K. N. Gonda X. Baghai T. C. et al. Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy. Int J Psychiatry Clin Pract: 2015; 19 158 167
82. Gibbons R. D. Hur K. Brown C. H. et al. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry: 2009; 66 1354 1360
83. Smith E. G. Austin K. L. Kim M. et al. Suicide risk in Veterans Health Administration patients with mental health diagnoses initiating lithium or valproate: historical prospective cohort study. BMC Psychiatry: 2014; 14 357
84. Ferrer P. Ballarín E. Sabaté M. et al. Antiepileptic drugs and suicide: Systematic review of adverse effects. Neuroepidemiol: 2014; 42 107 120
85. Mula M. Sander J. W. Suicide risk in people with epilepsy taking antiepileptic drugs. Bipolar Disord: 2013; 15 622 627
86. Siamouli M. Samara M. Fountoulakis K. N. Is antiepileptic-induced suicidality a data-based class effect or an exaggeration? A comment on the literature. Harv Rev Psychiatry: 2014; 22 379 381
87. Akiskal H. S. Benazzi F. Perugi G. et al. Agitated unipolar depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord: 2005; 85 245 258
88. Sim K. Lau W. K. Sim J. et al. Prevention of relapse and recurrence in adults with major depressive disorder: Systematic review and meta-analyses of controlled trials. Intl J Neuropsychopharmacol: 2015; 19 1 13
89. Sondergård L. Kvist K. Lopez A. et al. Temporal changes in suicide rates for persons treated and not treated with antidepressants in Denmark during 1995-1999. Acta Psychiatr Scand: 2006; 114 168 176
90. Tondo L. Isacsson G. Baldessarini R. Suicidal behavior in bipolar disorder: Risk and prevention. CNS Drugs: 2003; 17 491 511
91. Undurraga J. Baldessarini R. J. Randomized placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology: 2012; 37 1 14
92. Yatham L. N. Kennedy S. H. Schaffer et al Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disord (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2009. Bipolar Disord: 2009; 11 225 255
93. Jakobsen J. C. Katakam K. K. Schou A. et al. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder systematic review with meta-analysis and trial sequential analysis. BMC Psychiatry: 2017; 17 58 86
94. Ghaemi S. N. Wingo A. P. Filkowski M. A. et al. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand: 2008; 118 347 356
95. Vázquez G. Tondo L. Baldessarini R. J. Comparison of antidepressant responses in patients with bipolar vs unipolar depression: A meta-analytic review. Pharmacopsychiatry: 2011; 44 21 22
96. Tondo L. Baldessarini R. J. Vázquez G. et al. Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders. Acta Psychiatr Scand: 2013; 127 355 364
97. El-Mallakh R. S. Vöhringer P. A. Ostacher M. M. et al. Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial. J Affect Disord: 2015; 184 318 321
98. Baldessarini R. J. Lau W. K. Sim J. et al. Suicidal risks in reports of long-term treatment trials for major depressive disorder. Int J Neuropsychopharmacol: 2015; 19 pyv107
99. Bottlender R. Rudolf D. Strauss A. et al. Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients. J Affect Disord: 2001; 63 79 83
100. Braun C. Bschor T. Franklin J. et al. Suicides and suicide attempts during long-term treatment with antidepressants: meta-analysis of 29 placebo-controlled studies including 6,934 patients with major depressive disorder. Psychother Psychosom: 2016; 85 171 179
101. Gaertner I. Gilot C. Heidrich P. et al. A case-control study on psychopharmacotherapy before suicide committed by 61 psychiatric inpatients. Pharmacopsychiatry: 2002; 35 37 43
102. Khan A. Warner H. A. Brown W. A. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the Food and Drug Administration database. Arch Gen Psychiatry: 2000; 57 311 317
103. Laughren T. Overview of a Meeting of the Psychopharmacology Drug Advisory Committee (PDAC) Concerning Suicidal Risk in Trials of Antidepressant Drugs in Juvenile and Adult Patients; 2006 Accessed at: https://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-fda.pdf Accessed on: February 5, 2018
104. Möller H. J. Antidepressants: Controversies about their efficacy in depression their effect on suicidality and their place in a complex psychiatric treatment approach. World J Biol Psychiatry: 2009; 10 180 195
105. Reseland S. Bray I. Gunnell D. Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries. Br J Psychiatry: 2006; 188 354 358
106. Valuck R. J. Libby A. M. Anderson H. D. et al. Comparison of antidepressant classes and the risk and time course of suicide attempts in adults: Propensity matched retrospective cohort study. Br J Psychiatry: 2016; 208 271 279
107. Wise J. Antidepressants may double risk of suicide and aggression in children study finds. BMJ: 2016; 352 i545
108. Yerevanian B. I. Choi Y. M. Impact of psychotropic drugs on suicide and suicidal behaviors. Bipolar Disord: 2013; 15 594 621
109. Zisook S. Trivedi M. H. Warden D. et al. Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR∗D study. J Affect Disord: 2009; 117 63 73
110. Perugi G. Angst J. Azorin J. M. et al. Mixed features in patients with a major depressive episode: The BRIDGE-II-MIX study. J Clin Psychiatry: 2015; 76 e351 e358
111. Hammad T. A. Laughren T. P. Racoosin J. A. Suicide rates in short-term randomized controlled trials of newer antidepressants. J Clin Psychopharmacol: 2006; 26 203 207
112. Popovic D. Vieta E. Azorin J. M. et al. Suicide attempts in major depressive episode: Evidence from the BRIDGE-II-Mix study. Bipolar Disord: 2015; 17 795 803
113. Tollefson G. D. Rampey A. H. Beasley C. M. et al. Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression. J Clin Psychopharmacol: 1994; 14 163 169
114. Baldessarini R. J. Tondo L. Strombom I. M. et al. Ecological studies of antidepressant treatment and suicidal risks. Harv Rev Psychiatry: 2007; 15 133 145
115. Ghaemi S. N. Hsu D. J. Soldani F. et al. Antidepressants in bipolar disorder: The case for caution. Bipolar Disord: 2003; 5 421 433
116. Stone M. B. The FDA warning on antidepressants and suicidality: Why the controversy? N Engl J Med: 2014; 371 1668 1671
117. Tondo L. Lepri B. Baldessarini R. J. Suicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorder. Acta Psychiatr Scand: 2008; 118 106 151
118. Bridge J. Iyengar S. Salary C. B. et al Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA: 2007; 297 1683 1696
119. Gibbons R. D. Brown C. H. Hur K. et al. Relationship between antidepressants and suicide attempts: An analysis of the Veterans Health Administration data sets. Am J Psychiatry: 2007; 164 1044 1049
120. Isacsson G. Holmgren A. Osby U. et al. Decrease in suicide among the individuals treated with antidepressants: A controlled study of antidepressants in suicide, Sweden 1995-2005. Acta Psychiatr Scand: 2009; 120 37 44
121. Barbui C. Esposito E. Cipriani A. Selective serotonin reuptake inhibitors and risk of suicide: A systematic review of observational studies. CMAJ: 2009; 180 291 297
122. Hammad T. A. Laughren T. Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry: 2006; 63 332 339
123. Selle V. Schalkwijk S. Vázquez G. H. et al. Treatments for acute bipolar depression: meta-analyses of placebo-controlled monotherapy trials of anticonvulsants lithium and antipsychotics. Pharmacopsychiatry: 2014; 47 43 52
124. Vázquez G. H. Holtzman J. N. Tondo L. et al. Efficacy and tolerability of treatments for bipolar depression. J Affect Disord: 2015; 183 258 262
125. Tondo L. Albert M. J. Baldessarini R. J. Suicide rates in relation to health care access in the United States: An ecological study. J Clin Psychiatry: 2006; 67 517 523
126. Tiihonen J. Lönnqvist J. Wahlbeck K. et al. Eleven-year follow-up of mortality in patients with schizophrenia: A population-based cohort study (FIN11 study). Lancet: 2009; 374 620 627
127. Tiihonen J. Mittendorfer-Rutz E. Torniainen M. et al. Mortality and cumulative exposure to antipsychotics antidepressants and benzodiazepines in patients with schizophrenia: an observational follow-up study. Am J Psychiatry: 2016; 173 600 606
128. Torniainen M. Mittendorfer-Rutz E. Tanskanen A. et al. Antipsychotic treatment and mortality in schizophrenia. Schizophr Bullet: 2015; 41 656 663
129. Wimberley T. MacCabe J. H. Laursen T. M. et al. Mortality and self-harm in association with clozapine in treatment-resistant schizophrenia. Am J Psychiatry: 2017; 174 990 998
130. Goodwin F. K. Anticonvulsant therapy and suicide risk in affective disorders. J Clin Psychiatry: 1999; 60 89 93
131. Kovacsics C. E. Gottesman I. I. Gould T. D. Lithium's antisuicidal efficacy: Elucidation of neurobiological targets using endophenotype strategies. Ann Rev Pharmacol Tox: 2009; 49 175 198
132. Müller-Oerlinghausen B. Lewitzka U. Lithium reduces pathological aggression and suicidality: A mini-review. Neuropsychobiology: 2010; 62 43 49
133. Swann A. C. Mixed features: Evolution of the concept past and current definitions and future prospects. CNS Spectr: 2017; 22 161 169
134. Ahrens B. Müller-Oerlinghausen B. Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry: 2001; 34 132 136
135. Bschor T. Bauer M. Efficacy and mechanisms of action of lithium augmentation in refractory major depression. Curr Pharmaceut Design: 2006; 12 2985 2992
136. Lewitzka U. Severus E. Bauer R. et al The suicide prevention effect of lithium: More than 20 years of evidence - a narrative review. Int J Bipolar Disord: 2015; 3 32